TY - JOUR T1 - Mathematical Model Based COVID-19 Prediction in India and its Different States JF - medRxiv DO - 10.1101/2020.05.16.20104232 SP - 2020.05.16.20104232 AU - Jaspreet Singh AU - P. K. Ahluwalia AU - Ashok Kumar Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/05/18/2020.05.16.20104232.abstract N2 - By employing the successive approximation method to the real-time data of India and its different states, we have predicted the bounds of the spread of COVID-19 in India and its various states. The calculated lower and upper bound of patients (deaths) till 10th June 2020 comes out to be 79496 (3835) and 241759 (7045), respectively. States like Delhi, Gujarat, Maharashtra, Punjab, Rajasthan and Tamil Nadu are the spike states as suggested by the range of expected COVID-19 patients and deaths. Impact of return of stranded pilgrims from Nanded (Maharashtra) has also been looked into in the case of Punjab. It has been found that Punjab may see ~ 5 times increase in the lower bound of expected patients till 10th June 2020 due to the return of pilgrims from Maharashtra. Our study provides an insight into the possible number of expected patients and deaths in near future that may be of importance for the respective governments to be ready with the appropriate preventive measures and logistics to put appropriate infrastructure and medical facilities in place to manage the spread of deadly virus and go down the flattening curve.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo Funding for this work.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesN/A ER -